Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» LY2963016
LY2963016
Could These Potential Catalysts Drive Lilly Higher?
Motley Fool
Tue, 02/4/14 - 06:58 pm
Eli Lilly
Evista
Zyprexa
Cymbalta
generics
solanezumab
Alzheimer's disease
LY2963016
diabetes
empagliflozin
dulaglutide
What Does the Patent Cliff Mean for This Drugmaker?
Motley Fool
Fri, 07/26/13 - 09:05 am
patent cliff
Eli Lilly
Merck
Pfizer
Prozac
LY2963016
Zyprexa
Cymbalta
Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product
Yahoo
Mon, 07/8/13 - 09:43 am
diabetes
Eli Lilly
Boehringer Ingelheim
Europe
LY2963016
long-acting insulin
biosimilars
Eli Lilly's Big Bet On Diabetes
Seeking Alpha
Tue, 04/23/13 - 07:54 am
Eli Lily
diabetes
insulin
LY2605541
dulaglutide
LY2963016
empagliflozin